Pazopanib: in advanced soft tissue sarcoma.

Pazopanib: in advanced soft tissue sarcoma.

Item
http://www.wikidata.org/entity/Q42715298
Oral targeted therapy for cancerThe importance of treating by histological subtype in advanced soft tissue sarcoma.Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen.Soft tissue sarcomas, a look into the future: different treatments for different subtypes.Trabectedin clinical cases: use according to indication in diverse clinical scenarios.Pharmacokinetic Aspects of Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors.The Patient Experience with Soft Tissue Sarcoma: A Systematic Review of the Literature.Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization fImmunotherapeutic Targeting of Tumor-Associated Blood Vessels.Development and validation of a micellar liquid chromatographic method to determine three antitumorals in plasma.
P2860

Pazopanib: in advanced soft tissue sarcoma.

Item
http://www.wikidata.org/entity/Q42715298
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Pazopanib: in advanced soft tissue sarcoma.
@en
Pazopanib: in advanced soft tissue sarcoma.
@nl
type
label
Pazopanib: in advanced soft tissue sarcoma.
@en
Pazopanib: in advanced soft tissue sarcoma.
@nl
prefLabel
Pazopanib: in advanced soft tissue sarcoma.
@en
Pazopanib: in advanced soft tissue sarcoma.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Pazopanib: in advanced soft tissue sarcoma.
@en
P2093
P2860
P2888
P304
P31
P356
10.2165/11209950-000000000-00000
P433
P478
P577
P6179
P698
P921